Home > Income Statement > CORONA REMEDIES

CORONA REMEDIES
Revenue

    Back to Income Statement
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Net Sales ₹1,196 Cr₹10,145 Cr₹884 Cr₹884 Cr

What is the latest Revenue of CORONA REMEDIES ?

The latest Revenue ratio of CORONA REMEDIES is ₹1,196 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹1,196 Cr
Mar2025₹10,145 Cr
Mar2024₹884 Cr
Mar2023₹884 Cr

How is Revenue of CORONA REMEDIES Trending?

Years Revenue % Change
Mar2026 ₹1,196 Cr
-88.21
Mar2025 ₹10,145 Cr
1,047.53
Mar2024 ₹884 Cr
0.00
Mar2023 ₹884 Cr -

Compare Revenue of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹13,598.9 Cr 6.5% 3.6% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,278.0 Cr -2.5% -4.7% 15.5% Stock Analytics
DIVIS LABORATORIES ₹243,966.0 Cr -4% 8.1% 55.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,478.0 Cr -2.3% 0.2% 36.6% Stock Analytics
CIPLA ₹109,950.0 Cr -1.7% -6.1% -12% Stock Analytics
DR REDDYS LABORATORIES ₹95,967.4 Cr -0.2% -4.4% -10.2% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

6.5%

3.6%

NA
SENSEX

-2.8%

-5.2%

-8.4%


You may also like the below Video Courses